Sales and Marketing

Showing 15 posts of 11526 posts found.

immatics appoints Dr Rainer Kramer as its new
 chief business officer

April 12, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

immatics biotechnologies, a biopharma company developing therapeutic cancer vaccines, has appointment Dr Rainer Kramer as its new chief business officer. …

Algeta to co-promote Alpharadin in US

April 12, 2012 Sales and Marketing Algeta, Bayer, prostate cancer

Algeta has exercised its option to co-promote Alpharadin for the treatment of cancer patients with bone metastases in the United …

Humira gains European licence for ulcerative colitis

April 11, 2012 Sales and Marketing Humira, ulcerative colitis

Abbott’s Humira has gained European approval to treat ulcerative colitis, adding to its six existing licences.   It can now …
Amgen

Amgen to acquire kidney disease specialist for $315m

April 11, 2012 Sales and Marketing Amgen, KAI Pharmaceuticals

Amgen will acquire KAI Pharmaceuticals for $315 million to bolster its late-stage pipeline. The deal, which should be completed within …

Investors ramp up pressure on AZ chief

April 10, 2012 Sales and Marketing AstraZeneca, David Brennan

AstraZeneca’s chief executive David Brennan is coming under increasing pressure from investors, and his future at the firm could be …

Alzheimer’s diagnostic comes with caveats

April 10, 2012 Sales and Marketing Alzheimer's, Amyvid, lilly

A first-in-class test for Alzheimer’s disease has been approved by the FDA, but its makers have stressed its limitations.Lilly’s Amyvid …
Novo Nordisk HQ

Victoza superiority to Januvia made official by FDA

April 10, 2012 Medical Communications, Sales and Marketing Januvia, Merck, Novo Nordisk, Victoza, diabetes

Novo Nordisk is now able to claim superiority for its diabetes drug Victoza compared to Merck’s rival treatment Januvia.The US …

Sheri McCoy resigns from Johnson & Johnson

April 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Johnson & Johnson, Sheri McCoy, resignation

Johnson & Johnson has announced that Sheri McCoy, vice chairman of the executive committee, will leave the company on April …

Submission of labels and leaflets in the UK

April 5, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Labelling, Wainwright Associates

The MHRA has announced procedural changes concerning the requirement to submit full-colour mock-ups of labels and patient leaflets for medicinal …

Pfizer heart drug gains new licence in UK

April 5, 2012 Sales and Marketing Inspra, NHS, Pfizer, heart failure

Pfizer’s heart pill Inspra has gained a new licence in the UK to reduce the risk of death in patients …
Brain image

The brain drain

April 5, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, R&D, brain drain, research and development

Concerns about the growing number of companies disinvesting from neuroscience research have been growing in recent years, and the latest …

Eric Abadie resigns as chair of the CHMP

April 5, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CHMP, Eric Abadie

Dr Eric Abadie has told the European Medicines Agency that he is resigning as chair of the Committee for Medicinal …

FDA grants priority review for Sanofi cancer drug

April 5, 2012 Research and Development, Sales and Marketing Erbitux, FDA, Regeneron, Sanofi, Zaltrap, colorectal cancer, prostate cancer

The FDA has granted Sanofi and partner Regeneron priority review for their colorectal cancer drug Zaltrap. Zaltrap (aflibercept) is seeking a …

Orphan Medicinal Products in the EU- Free Webinar

April 4, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Orphan Medicinal Products in the EU: Eligibility, Orphan Designation and IncentivesThe structure of this webinar is:Introduction: Legislative Basis and Criteria …

NHS spending on drugs fell in 2011

April 4, 2012 Sales and Marketing NHS, cost savings, generic, patent, prescriptions, spend

The NHS in England spent less on its drugs budget last year, bucking the longstanding upward trend. This is because …
The Gateway to Local Adoption Series

Latest content